ne 58051 has been researched along with butyrolactone i in 1 studies
| Studies (ne 58051) | Trials (ne 58051) | Recent Studies (post-2010) (ne 58051) | Studies (butyrolactone i) | Trials (butyrolactone i) | Recent Studies (post-2010) (butyrolactone i) |
|---|---|---|---|---|---|
| 17 | 0 | 2 | 118 | 0 | 26 |
| Protein | Taxonomy | ne 58051 (IC50) | butyrolactone i (IC50) |
|---|---|---|---|
| G1/S-specific cyclin-E2 | Homo sapiens (human) | 1.5 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.6 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.6 | |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | 1.5 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
1 other study(ies) available for ne 58051 and butyrolactone i
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |